References
- Ang KK, Mason KA, Meyn RE (2002). Epidermal growth factor receptor (EGFR) and its inhibition in radiotherapy; 7th International Meeting on Progress in Radio-OncologyICRO/PGRO; Salzburg, Austria: Medimond, Inc pp 557-67.
- Carracedo A, Pandolfi PP (2008). The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene, 27, 5527-41. https://doi.org/10.1038/onc.2008.247
- Chen DJ, Nirodi CS (2007). The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res, 13, 6555-60. https://doi.org/10.1158/1078-0432.CCR-07-1610
- Fryknas M, Dhar S, Oberg F, et al (2007). STAT1 signaling is associated with acquired cross resistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer, 120, 189-95. https://doi.org/10.1002/ijc.22291
- Golding SE, Morgan RN, Asams BR, et al (2009). Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol Ther, 8, 730-8. https://doi.org/10.4161/cbt.8.8.7927
- Hiro J, Inoue Y, Toiyama Y, Miki C, Kusunoki M (2008). Mechanism of resistance to chemoradiation in p53 mutant human colon cancer. Int J Oncol, 32, 1305-10.
- Khodarev NN, Minn AJ, Efimova EV, et al (2007). Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res, 67, 9214-20. https://doi.org/10.1158/0008-5472.CAN-07-1019
- Kriegs M, Kasten-Pisula U, Rieckmann T, et al (2010). The epidermal growth factor receptor modulates DNA doublestrand break repair by regulating non-homologous endjoining. DNA Repair (Amst), 9, 889-97. https://doi.org/10.1016/j.dnarep.2010.05.005
- Liccardi G, Hartley JA, Hochhauser D (2011). EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res, 71, 1103-14. https://doi.org/10.1158/0008-5472.CAN-10-2384
- Meister N, Shalaby T, von Bueren AO, et al (2007). Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy. Eur J Cancer, 43, 1833-41. https://doi.org/10.1016/j.ejca.2007.05.028
- Meyn RE, Munshi A, Haymach JV, Milas L, Ang KK (2009). Signaling as a regulatory mechanism of DNA repair. Radiother Oncol, 92, 316-22. https://doi.org/10.1016/j.radonc.2009.06.031
- Mukherjee B, Choy H, Nirodi C, Burma S (2010). Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization. Semin Radiat Oncol, 20, 250-7. https://doi.org/10.1016/j.semradonc.2010.05.002
- Ono M, Kuwano M (2006). Molecular mechanisms of epidermal growth factor receptor (EGFR) activationand response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res, 12, 7242-51. https://doi.org/10.1158/1078-0432.CCR-06-0646
- Rodemann HP, Dittmann K, Toulany M (2007). Radiationinduced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol, 83, 781-91. https://doi.org/10.1080/09553000701769970
- Sartor CI (2004). Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors. Nat Clin Pract Oncol, 1, 80-7.
- Szumiel I (2006). Epidermal growth factor receptor and DNA double strand break repair: the cell's self-defence. Cell Signal, 18, 1537-48. https://doi.org/10.1016/j.cellsig.2006.03.010
- Tanaka T, Munshi A, Brooks C, et al (2008). Gefitinibradiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity. Clin Cancer Res, 14, 1266-73. https://doi.org/10.1158/1078-0432.CCR-07-1606
- Toulany M, Dittmann K, Fehrenbacher B, et al (2008). PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. DNA Repair (Amst), 7, 1746-56. https://doi.org/10.1016/j.dnarep.2008.06.017
- Toulany M, Kehlbach R, Florczak U, et al (2008). Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther, 7, 1772-81. https://doi.org/10.1158/1535-7163.MCT-07-2200
- Toulany M, Rodemann HP (2010). Membrane receptor signaling and control of DNA repair after exposure toionizing radiation. Nuklearme Dizin, 49, S26-30.
Cited by
- Roles of glucose transporter-1 and the phosphatidylinositol 3-kinase/protein kinase B pathway in cancer radioresistance (Review) vol.11, pp.3, 2014, https://doi.org/10.3892/mmr.2014.2888
- Superparamagnetic Iron Oxide Nanoparticles as Novel X-ray Enhancer for Low-Dose Radiation Therapy vol.118, pp.23, 2014, https://doi.org/10.1021/jp5026224
- Loss of Urokinase Receptor Sensitizes Cells to DNA Damage and Delays DNA Repair vol.9, pp.7, 2014, https://doi.org/10.1371/journal.pone.0101529
- Isogenic radiation resistant cell lines: Development and validation strategies vol.90, pp.2, 2014, https://doi.org/10.3109/09553002.2014.873557
- Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2750-y
- Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR protein vol.12, pp.7, 2017, https://doi.org/10.1371/journal.pone.0180604
- shRNA-Mediated XRCC2 Gene Knockdown Efficiently Sensitizes Colon Tumor Cells to X-ray Irradiation in Vitro and in Vivo vol.15, pp.2, 2014, https://doi.org/10.3390/ijms15022157
- Receptor tyrosine kinase signaling in cancer radiotherapy and its targeting for tumor radiosensitization vol.94, pp.7, 2018, https://doi.org/10.1080/09553002.2018.1478160